New Atopic Dermatitis Business Unit Director for LEO Pharma
Nadege Feeser joins the specialist dermatology company to lead the expanding team
August 24 2020, Hurley, Berks, UK
LEO Pharma UK/Ireland, the leading medical dermatology company, has appointed Nadege Feeser to drive its transformative journey in atopic dermatitis for its North Europe ‘cluster’ countries.
Nadege has over 17 years of strategic and operational experience across biotech and big pharma, most recently at Novartis in Switzerland where she was a Global Marketing Director for Cosentyx, and brings with her significant immuno-dermatology experience. After 6 years in regional and global roles in Basel, Nadege is keen to come to the UK to continue her leadership journey through learning and building an incredible AD team grounded in a culture of appreciation and collaboration. Before coming to the UK, Nadege spent more than 10 years in countries like France and emerging markets with Eisai, BMS and Novartis in marketing and sales roles.
Commenting on why she was attracted to the opportunity at LEO Pharma, Nadege Feeser explained,“I am delighted to be joining LEO Pharma at this exciting time in its history: It really does feel like a time of great optimism and transformation. We have an amazing opportunity to make a real difference to peoples’ lives, as we strive to accelerate access to treatment for underserved atopic dermatitis patients with a high unmet need. I feel privileged and grateful to contribute to a better quality of life for patients together with my team.”
“I am thrilled to welcome Nadege to LEO Pharma. It is clear that she is passionate about changing the treatment paradigm for patients living with atopic dermatitis where there exists such a high level of need for additional therapies and support. Nadege will bring a lot of insights and experience to our business and I am looking forward to working with her in my leadership team”, said Geraldine Murphy, Managing Director UK and Ireland.
UK/IE MAT-34066 August 2020
Media contact information:
About LEO Pharma
The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 92 million patients in 130 countries.
For more information about LEO Pharma UK/IE:
Follow us on Twitter: twitter.com/LEOPharmaUKIE
Subscribe to our YouTube channel: www.youtube.com/channel/UC_HWf4kPkN5Z3Po6_KfN9xw
Check out our LEO Pharma UK/IE LinkedIn Life Page: www.linkedin.com/company/leo-pharma/life/